News | August 18, 2025
European Commission grants approval of Ogsiveo
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
The company received one observation in the Form-483
The company received 1 (One) observation in the Form-483
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Subscribe To Our Newsletter & Stay Updated
